03:39 AM EDT, 08/06/2024 (MT Newswires) -- RxSight ( RXST ) reported late Monday breakeven Q2 adjusted earnings per diluted share, compared with a loss of $0.28 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.11.

Revenue for the quarter ended June 30 was $34.9 million, up from $20.8 million a year earlier.

Three analysts surveyed by Capital IQ expected $32.1 million.

The company raised its full-year 2024 revenue guidance to a range of $139 million to $140 million from prior guidance of $132 million to $137 million. Analysts surveyed by Capital IQ expect $139.6 million.

Price: 49.30, Change: +8.52, Percent Change: +20.89